Skip to main content

Table 4 Reason for declining study participation

From: Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

Source Time commitments Location Not interested Other Drug concerns
Clinics 13 (16%) 1 (1%) 8 (10%) 2 (3%) 1 (1%)
Register 15 (19%) 6 (8%) 1 (1%) 3 (4%) 0 (0%)
Internet 18 (23%) 7 (9%) 3 (4%) 2 (3%) 0 (0%)